New FDA draft guidance aims to foster oncology product development for pediatric populations. Will new guidance result in new products for these patients?
Want to dig deeper into pediatric therapeutic development?
-
Article
Paediatric Drug Development: The Journey Continues
Read Now
Sandra Blumenrath, Ronald Portman
PharmaTimes -
Article
Innovation and Opportunities in Pediatric Therapeutic Development
Read Now
Susan McCune et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Tiny and Forgotten: A Call for Focused Neonatal Policy Reform
Read Now
Christina Bucci-Rechtweg et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Incorporating Innovative Techniques Toward Extrapolation and Efficient Pediatric Drug Development
Read Now
Margaret Galamo-Siebers et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Pharmacometrics in Pediatrics
Read Now
Xiaoxi Liu et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Impact of Regulatory Incentive Programs on the Future of Pediatric Drug Development
Read Now
Elizabeth Yen et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Role of Patients and Parents in Pediatric Drug Development
Read Now
Vivian W. L. Tsang et al.
Therapeutic Innovation & Regulatory Science
Member-only content
Want to learn more about pediatric therapeutic development?
Watch member-only Insider Access highlights from Global Pediatric Policy Update: Are You Ready to Implement FDARA Section 504? New Insider Access features: Follow along with the interactive transcript, or download the audio file to learn on the go!
Related Perspectives
View all Deep Dives-
Article
From The New York Times: New Strawberry-Flavored HIV Drugs for Babies Offered at $1 a Day
Read Now -
Article
From Medscape: FDA OKs First System for In-Office Tympanostomy Tube Placement
Read Now -
Article
From MD Magazine: FDA Approves Botox for Lower Limb Spasticity in Pediatric Patients
Read Now